Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy

by Lui, Y.Y.N., Tsoi, K.K.F., Wong, V.W.S., Kao, J.H., Hou, J.L., Teo, E.K., Mohamed, R., Piratvisuth, T., Han, K.H., Mihm, U., Wong, G.L.H., Chan, H.L.Y.
Published 2010

Prevention of hepatocellular carcinoma in the Asia-Pacific region: Consensus statements

by Farrell, G.C., Chan, H.L.Y., Yuen, M.F., Amarapurkar, D.N., Chutaputti, A., Fan, J.G., Hou, J.L., Han, K.H., Kao, J.H., Lim, S.G., Mohamed, R., Sollano, J., Ueno, Y., Prevent, Asai-Pacific Working Party
Published 2010

Practical difficulties in the management of hepatitis B in the Asia-Pacific region

by Mohamed, R., Desmond, P., Suh, D.-J., Amarapurkar, D., Gane, E., Guangbi, Y., Hou, J.-L., Jafri, W., Ching, L.L., Lee, C.-H., Lee, S.-D., Seng, G.L., Guan, R., Pham, H.P., Piratvisuth, T., Sollano, J., Wu, J.-C.
Published 2016